Illumina Inc
ILMNStock
$190.25+92.64%52W
Market Cap$28.50B
P/E33.52x
Div yield—
Beta1.48
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)15.19%
Price vs S&P 500 (4W)13.32%
VGM Score51.19
Market Capitalization$28.50B
P/E Ratio (Annual)33.52x
Earnings Surprise History
Q1 261.15est. 1.08
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
3.68
3.68
3.75
3.71
Industry Peers — Lab Analytical Instruments(24)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ILMNIllumina Inc | D | D | A | $190.25 |
| AAgilent Technologies Inc. | C | C | B | $136.10 |
| WATWaters Corp | D | C | B | $378.19 |
| MTDMettler-Toledo International | D | C | C | $1335.09 |
| RVTYRevvity, Inc. | C | D | B | $111.70 |
| BRKRBruker Corporation | D | D | B | $59.25 |
| BIOBio-Rad Laboratories, Inc.Class A | C | F | B | $300.98 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | F | B | $309.37 |
| AVTRAvantor, Inc. | B | F | B | $11.26 |
| TXG10x Genomics, Inc. Class A Common Stock | F | C | A | $44.48 |
| ALMRAlamar Biosciences, Inc. Common Stock | — | — | A | $24.95 |
About
Illumina is a leading provider of genetic analysis tools and services for life science and clinical applications. The company derives over 90% of revenue from sequencing instruments, consumables, and related services, offering both high-throughput whole genome sequencing and targeted solutions for viral and cancer detection. Illumina also operates a microarray business (9% of 2024 revenue) serving consumer genomics and agricultural markets with more cost-effective genetic screening options.